Molecular Templates, Inc.
🏢 View company profile →26Patents
25Active
26Granted
50Portfolio score
Filing activity: Dec 8, 1998 → Jun 9, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10815469B2 | Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties | Chemistry; Metallurgy | 19 | Active |
| US7713915B1 | Cytotoxic heteromeric protein combinatorial libraries | Human Necessities | 14 | Expired |
| US10421958B2 | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity | Physics | 10 | Active |
| US11136395B2 | PD-L1 -binding molecules comprising Shiga toxin A subunit scaffolds | Chemistry; Metallurgy | 9 | Active |
| US11312751B2 | MHC class I epitope delivering polypeptides | Chemistry; Metallurgy | 5 | Active |
| US11365223B2 | De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same | Chemistry; Metallurgy | 5 | Active |
| US11225509B2 | HER2-targeting molecules comprising de-immunized, Shiga toxin A subunit scaffolds | Chemistry; Metallurgy | 4 | Active |
| US11389542B1 | Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation | Chemistry; Metallurgy | 3 | Active |
| US11857628B2 | Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation | Chemistry; Metallurgy | 3 | Active |
| US11713347B2 | CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors | Chemistry; Metallurgy | 3 | Active |
| US11406692B2 | Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes | Chemistry; Metallurgy | 3 | Active |
| US11918649B2 | PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds | Chemistry; Metallurgy | 1 | Active |
| US11142584B2 | CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same | Physics | 0 | Active |
| US10392425B2 | Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US12065469B2 | De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals | Chemistry; Metallurgy | 0 | Active |
| US11104707B2 | Multivalent CD20-binding molecules comprising Shiga toxin a subunit effector regions and enriched compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US10760130B2 | Predictive biomarker for hypoxia-activated prodrug therapy | Physics | 0 | Active |
| US10668047B2 | Aziridine containing DNA alkylating agents | Chemistry; Metallurgy | 0 | Active |
| US11248061B2 | Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US10654876B2 | TH-302 solid forms and methods related thereto | Chemistry; Metallurgy | 0 | Active |
| US10131683B2 | TH-302 solid forms and methods related thereto | Chemistry; Metallurgy | 0 | Active |
| US10450354B2 | CD20-binding immunotoxins for inducing cellular internalization and methods using same | Chemistry; Metallurgy | 0 | Active |
| US12037367B2 | MHC class I epitope delivering polypeptides | Chemistry; Metallurgy | 0 | Active |
| US12180284B2 | Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector | Physics | 0 | Active |
| US12180262B2 | CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.